The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

The multiplex PCR assays market size has seen rapid growth in recent years, anticipated to increase from $1.33 billion in 2023 to $1.51 billion in 2024, representing a compound annual growth rate (CAGR) of 13.4%. The historic growth in this market can be attributed to the rising prevalence of infectious diseases, increased government funding and support, the growing adoption of these assays in clinical diagnostics, a surge in genetic testing and personalized medicine, and advancements in bioinformatics and data analysis tools, alongside rising healthcare expenditures. Looking ahead, the multiplex PCR assays market size is expected to grow to $2.5 billion by 2028, with a CAGR of 13.5%. This growth is driven by the expansion of application areas, rising demand for point-of-care diagnostics, growth in personalized medicine, increased research and development expenditures, and an increasing focus on precision medicine, coupled with a rising demand for rapid and reliable diagnostic tests. Major trends anticipated in the forecast period include the integration of next-generation sequencing (NGS), advancements in companion diagnostics, digital PCR technology, automation and high-throughput systems, and the development of point-of-care and portable devices.

The increasing demand for diagnostic testing is expected to drive the growth of the multiplex PCR assay market in the coming years. Diagnostic testing refers to the procedures or tests employed to identify the presence or absence of diseases or conditions in patients. The growing demand for such testing is primarily due to the rise in chronic diseases like cancer and diabetes, which necessitate early and accurate diagnoses for effective management. Furthermore, the emphasis on preventive healthcare promotes regular testing to identify potential health issues early. Multiplex PCR assays enhance the efficiency and comprehensiveness of diagnostic testing by allowing the simultaneous detection and analysis of multiple pathogens or genetic markers from a single sample. For example, in July 2024, the National Health Service (NHS), a UK-based healthcare provider, reported that diagnostic activity surpassed pre-pandemic levels in 2023, with a 21% increase in tests conducted in May 2024 compared to the previous year, amounting to 2.4 million diagnostic tests. Thus, the increasing demand for diagnostic testing will significantly propel the multiplex PCR assay market’s growth through 2023, into 2024, and is anticipated to continue growing by 2028.

Get A Free Sample On The Multiplex PCR Assays Market Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18681&type=smp

What Are The Key Trends That Influence Multiplex PCR Assays Market Share Analysis?

Major companies in the multiplex PCR assays market are concentrating on incorporating automation, such as next-generation quantitative PCR (qPCR) systems, to facilitate precise and flexible nucleic acid quantification for advanced clinical diagnostics and public health. Next-generation qPCR systems enable high-throughput, accurate, and simultaneous detection of multiple targets, thereby enhancing diagnostic accuracy and efficiency. For example, in November 2023, Roche Diagnostics Corporation, a Switzerland-based diagnostic system manufacturer, launched the LightCycler PRO System. This next-generation qPCR platform offers high-throughput capabilities, precise detection of multiple targets, enhanced temperature uniformity, advanced software, and compatibility with over 200 LightMix Modular and 60 CE-IVD assays, thereby improving diagnostic accuracy and efficiency. This system exemplifies the integration of automation within the multiplex PCR assays market, advancing clinical diagnostics and public health.

Which Market Players Are Driving Growth In The Multiplex PCR Assays Market?

Major companies operating in the multiplex pcr assays market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc, Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers, Becton Dickinson and Company, Agilent Technologies Inc, PerkinElmer Inc, Illumina Inc, Sysmex Corporation, Bio-Rad Laboratories Inc, QIAGEN NV, Tecan Group Ltd, DiaSorin SpA, Bio-Techne Corporation, Promega Corporation, Randox Laboratories Ltd, BioFire Diagnostics Inc, Seegene Inc, Quanterix Corporation, NanoString Technologies, Standard BioTools Inc, Enzo Biochem Inc, SeraCare Life Sciences Inc, Agena Bioscience, Fluidigm Corporation

How Is The Global Multiplex PCR Assays Market Segmented?

The multiplex pcr assays market covered in this report is segmented –

1) By Assay Type: Planar Assay, Bead Based Assay
2) By Product And Services: Consumables, Instruments, Software And Services
3) By Application: Disease Diagnosis, Research And Development, Other Applications
4) By End User: Biopharmaceutical Companies, Clinical Research Organizations, Academic Research Institutes, Diagnostic Centers, Other End Users

Read The Full Multiplex PCR Assays Market Report Here

https://www.thebusinessresearchcompany.com/report/multiplex-pcr-assays-global-market-report

The Multiplex PCR Assays Global Market Report 2024 provides an overview of the multiplex pcr assaysmarket for the time series: historic years (2010 – 2021) and ten years forecast (2023 – 2032). The multiplex pcr assays market forecast analyzes multiplex pcr assays market size, multiplex pcr assays market share, leading competitor and their market positions.

The Table Of Content For The Multiplex PCR Assays Market Include

1. Multiplex PCR Assays Market Executive Summary
2. Multiplex PCR Assays Market Segments
3. Multiplex PCR Assays Market Size And Template Market Growth Rate
4.  Key Multiplex PCR Assays Market Trends
5. Major Multiplex PCR Assays Market Drivers
……
25. Key Mergers And Acquisitions In The Multiplex PCR Assays Market
26. Top Multiplex PCR Assays Companies
27. Multiplex PCR Assays Market Opportunities And Strategies
28. Multiplex PCR Assays Market, Conclusions And Recommendations
29. Appendix

Explore Similar Reports From The Business Research Company:

Multiplex Assays Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/multiplex-assays-global-market-report

Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/polymerase-chain-reactions-devices-reagents-and-uses-global-market-report

PCR And Realtime PCR Testing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pcr-and-realtime-pcr-testing-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: